Wellington Management Group LLP Adaptive Biotechnologies Corp Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $2.1 Million - $3.81 Million	-56,311 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $5.69 Million - $8.28 Million	-126,503 Reduced 69.2%	56,311 $3.33 Million
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $11.4 Million - $15.5 Million	-317,810 Reduced 63.48%	182,814 $8.89 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $68.4 Million - $133 Million	-2,742,621 Reduced 84.56%	500,624 $24.2 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $54.5 Million - $110 Million	3,215,117 Added 11430.31%	3,243,245 $90.1 Million
Q4 2019 Feb 11, 2020	BUY	$24.56 - $32.8 $690,823 - $922,598	28,128 New	28,128 $842,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.